Published in J Biol Chem on December 03, 2010
The many faces of tau. Neuron (2011) 2.89
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med (2012) 2.39
Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J (2011) 1.32
Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J (2013) 1.31
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci (2015) 1.18
Tau in physiology and pathology. Nat Rev Neurosci (2015) 1.15
The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05
Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease. Front Physiol (2012) 1.05
Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res (2011) 1.04
Formation and propagation of tau oligomeric seeds. Front Neurol (2013) 1.04
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions. Front Cell Neurosci (2014) 1.03
Lessons from tau-deficient mice. Int J Alzheimers Dis (2012) 1.01
Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One (2012) 0.97
Connecting the dots between tau dysfunction and neurodegeneration. Trends Cell Biol (2014) 0.97
The role of extracellular Tau in the spreading of neurofibrillary pathology. Front Cell Neurosci (2014) 0.95
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis (2011) 0.94
Tau as a therapeutic target in neurodegenerative disease. Pharmacol Ther (2012) 0.92
Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS One (2014) 0.92
Regulation of human MAPT gene expression. Mol Neurodegener (2015) 0.90
MicroRNAs and the Regulation of Tau Metabolism. Int J Alzheimers Dis (2012) 0.89
Nuclear translocation uncovers the amyloid peptide Aβ42 as a regulator of gene transcription. J Biol Chem (2014) 0.88
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? Biochem Soc Trans (2014) 0.85
Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation. PLoS One (2014) 0.85
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination. Nat Neurosci (2015) 0.84
The involvement of cholinergic neurons in the spreading of tau pathology. Front Neurol (2013) 0.84
Thermodynamics of the interaction between Alzheimer's disease related tau protein and DNA. PLoS One (2014) 0.83
Tau: The Center of a Signaling Nexus in Alzheimer's Disease. Front Neurosci (2016) 0.81
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules (2016) 0.81
Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma. Int J Mol Sci (2015) 0.81
Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss. Sci Rep (2016) 0.81
Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathol Commun (2016) 0.80
Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles. J Biol Chem (2015) 0.80
Tau interconverts between diffusive and stable populations on the microtubule surface in an isoform and lattice specific manner. Cytoskeleton (Hoboken) (2014) 0.80
Roles of tau protein in health and disease. Acta Neuropathol (2017) 0.80
Cellular factors modulating the mechanism of tau protein aggregation. Cell Mol Life Sci (2015) 0.79
The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro. PLoS One (2014) 0.79
Potential mechanisms and implications for the formation of tau oligomeric strains. Crit Rev Biochem Mol Biol (2016) 0.79
Tau deletion promotes brain insulin resistance. J Exp Med (2017) 0.78
Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review). Mol Med Rep (2015) 0.78
Lessons from two prevalent amyloidoses-what amylin and Aβ have in common. Front Aging Neurosci (2013) 0.78
Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis. Mol Neurodegener (2016) 0.78
Mutations in MAPT give rise to aneuploidy in animal models of tauopathy. Neurogenetics (2013) 0.78
Variations in brain DNA. Front Aging Neurosci (2014) 0.78
Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol Neurobiol (2015) 0.77
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation. Acta Neuropathol Commun (2016) 0.77
Axotrophin/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding. Biochim Biophys Acta (2014) 0.77
Tau-mediated synaptic damage in Alzheimer's disease. Transl Neurosci (2015) 0.77
Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro. J Proteome Res (2013) 0.77
TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. Elife (2016) 0.77
Therapeutic and diagnostic challenges for frontotemporal dementia. Front Aging Neurosci (2014) 0.76
Nuclear Tau and Its Potential Role in Alzheimer's Disease. Biomolecules (2016) 0.76
Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau. Sci Rep (2016) 0.76
Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations. Front Aging Neurosci (2015) 0.75
Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury. Neural Regen Res (2016) 0.75
Protective Effects of Fucoidan on Aβ25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice. Mar Drugs (2017) 0.75
Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models. Sci Rep (2017) 0.75
Structural basis of nucleic acid recognition by FK506-binding protein 25 (FKBP25), a nuclear immunophilin. Nucleic Acids Res (2016) 0.75
Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Sci Rep (2016) 0.75
Ketamine induces tau hyperphosphorylation at serine 404 in the hippocampus of neonatal rats. Neural Regen Res (2013) 0.75
Neuroprotective Functions for the Histone Deacetylase SIRT6. Cell Rep (2017) 0.75
Genome instability in Alzheimer disease. Mech Ageing Dev (2016) 0.75
The mitotic tensegrity guardian tau protects mammary epithelia from katanin-like1-induced aneuploidy. Oncotarget (2016) 0.75
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside. Diagnostics (Basel) (2017) 0.75
A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival. Nat Commun (2017) 0.75
Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts. Front Neurosci (2017) 0.75
A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A (1975) 15.35
The distribution of tau in the mammalian central nervous system. J Cell Biol (1985) 7.47
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev (2000) 5.40
Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res (1990) 4.60
Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science (2007) 3.86
I will survive: DNA protection in bacterial spores. Trends Microbiol (2007) 2.40
Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell (1995) 2.15
Heat-induced formation of reactive oxygen species and 8-oxoguanine, a biomarker of damage to DNA. Nucleic Acids Res (2002) 1.82
The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. J Biol Chem (1984) 1.56
A novel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein. J Biol Chem (2002) 1.39
Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J Neurochem (2010) 1.33
The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amst) (2008) 1.32
Structure of a protein-DNA complex essential for DNA protection in spores of Bacillus species. Proc Natl Acad Sci U S A (2008) 1.27
Yeast Nhp6A/B and mammalian Hmgb1 facilitate the maintenance of genome stability. Curr Biol (2005) 1.24
Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem (2009) 1.22
A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J Cell Biol (1993) 1.20
p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci (2005) 1.15
Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci U S A (1990) 1.15
Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization. J Cell Sci (2006) 1.14
Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett (2003) 1.07
Stress inhibits nucleocytoplasmic shuttling of heat shock protein hsc70. Am J Physiol Cell Physiol (2005) 1.04
The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem (2006) 1.03
The aging brain: accumulation of DNA damage or neuron loss? Neurobiol Aging (2005) 1.03
Proteotoxic stress increases nuclear localization of ataxin-3. Hum Mol Genet (2009) 1.02
DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res (2009) 1.02
Regulation of FE65 nuclear translocation and function by amyloid beta-protein precursor in osmotically stressed cells. J Biol Chem (2008) 1.02
Binding to the minor groove of the double-strand, tau protein prevents DNA from damage by peroxidation. PLoS One (2008) 1.01
Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity. Environ Mol Mutagen (1999) 1.00
Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. Mol Biol Cell (2009) 1.00
Tau as a nucleolar protein in human nonneural cells in vitro and in vivo. Chromosoma (1996) 0.99
A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle (2008) 0.98
The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. Mutagenesis (1995) 0.98
HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. Retrovirology (2008) 0.96
Localization and in situ phosphorylation state of nuclear tau. Exp Cell Res (1995) 0.94
The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay. Mutat Res (1995) 0.94
A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration. Hum Mol Genet (2010) 0.93
Tau could protect DNA double helix structure. Biochim Biophys Acta (2003) 0.91
Presence of tau in isolated nuclei from human brain. Neurobiol Aging (1995) 0.90
Nuclear translocation of the phosphoprotein Hop (Hsp70/Hsp90 organizing protein) occurs under heat shock, and its proposed nuclear localization signal is involved in Hsp90 binding. Biochim Biophys Acta (2008) 0.89
The preferential binding of histone H1 to DNA scaffold-associated regions is determined by its C-terminal domain. Nucleic Acids Res (2004) 0.89
Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes. Glia (2002) 0.88
Mechanism of cell death induction by nitroxide and hyperthermia. Free Radic Biol Med (2005) 0.88
Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Biochem Biophys Res Commun (2006) 0.88
The fast halo assay: an improved method to quantify genomic DNA strand breakage at the single-cell level. Mutat Res (2006) 0.88
Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau. J Cell Biochem (2000) 0.88
Intracellular trafficking of a fiber-modified adenovirus using lipid raft/caveolae endocytosis. Mol Ther (2007) 0.85
Effect of phosphorylation and aggregation on tau binding to DNA. Protein Pept Lett (2002) 0.85
tau kinases in the rat heat shock model: possible implications for Alzheimer disease. Proc Natl Acad Sci U S A (2000) 0.80
New evidences on Tau-DNA interactions and relevance to neurodegeneration. Neurochem Int (2010) 0.79
Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism. Neurochem Res (2008) 0.79
Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology (2012) 2.87
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol (2004) 2.15
A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog (2008) 2.12
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med (2011) 1.87
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet (2010) 1.83
Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol (2006) 1.68
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res (2012) 1.41
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J Biol Chem (2007) 1.35
PART is part of Alzheimer disease. Acta Neuropathol (2015) 1.31
Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci U S A (2007) 1.30
Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol (2007) 1.26
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutat Res (2007) 1.22
Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta (2005) 1.21
Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomics (2008) 1.21
Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta (2009) 1.19
Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem (2003) 1.17
Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene (2004) 1.17
p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci (2005) 1.15
Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization. J Cell Sci (2006) 1.14
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. Lancet Neurol (2003) 1.12
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet (2011) 1.11
Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem (2003) 1.10
Binding of YY1 to the proximal region of the murine beta interferon promoter is essential to allow CBP recruitment and K8H4/K14H3 acetylation on the promoter region after virus infection. Mol Cell Biol (2006) 1.09
Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res (2010) 1.09
Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun (2014) 1.09
Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J Virol (2003) 1.08
From tau phosphorylation to tau aggregation: what about neuronal death? Biochem Soc Trans (2010) 1.08
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D. Cancer Res (2006) 1.07
Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J Neurosci (2012) 1.06
Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease. Front Physiol (2012) 1.05
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis (2009) 1.04
The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem (2006) 1.03
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol Dis (2005) 1.03
Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology (2009) 1.03
Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol (2002) 1.03
Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol Dis (2007) 1.02
Pin1 allows for differential Tau dephosphorylation in neuronal cells. Mol Cell Neurosci (2006) 1.02
Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochim Biophys Acta (2005) 1.01
ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J Neurosci Res (2006) 1.01
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study. J Alzheimers Dis (2013) 1.00
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis (2011) 1.00
Transcription factor YY1 associates with pericentromeric gamma-satellite DNA in cycling but not in quiescent (G0) cells. Nucleic Acids Res (2004) 1.00
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J Neurosci (2003) 0.98
Minocycline in phenotypic models of Huntington's disease. Neurobiol Dis (2005) 0.98
Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the in vitro micronucleus test: Determination of No-Observed-Effect Levels. Mutat Res (2009) 0.97
Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol Learn Mem (2010) 0.96
Association between caffeine intake and age at onset in Huntington's disease. Neurobiol Dis (2013) 0.94
Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms. J Biol Chem (2011) 0.94
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat Res (2006) 0.94
International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ Mol Mutagen (2011) 0.93
Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes (2012) 0.93
Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J Neurochem (2005) 0.91
An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna. Mutat Res (2003) 0.91
The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. Biochemistry (2004) 0.91
Study of serum interaction with a cationic nanoparticle: Implications for in vitro endocytosis, cytotoxicity and genotoxicity. Int J Pharm (2011) 0.91
Heptyl prodigiosin, a bacterial metabolite, is antimalarial in vivo and non-mutagenic in vitro. J Nat Toxins (2002) 0.91
Tau as a biomarker of neurodegenerative diseases. Biomark Med (2008) 0.91
Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. J Alzheimers Dis (2010) 0.91
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem (2002) 0.91
Control of protein-protein interactions: structure-based discovery of low molecular weight inhibitors of the interactions between Pin1 WW domain and phosphopeptides. J Med Chem (2005) 0.89
MicroRNAs and the Regulation of Tau Metabolism. Int J Alzheimers Dis (2012) 0.89